1 Hospenthal DR, "The role of antifungal susceptibility testing in the therapy of candidiasis" 48 : 153-160, 2004
2 Vandenbossche I, "Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory" 40 : 918-921, 2002
3 Patterson TF, "Simple method for detecting fluconazole-resistant yeasts with chromogenic agar" 34 : 1794-1797, 1996
4 Clinical and Laboratory Standards Institutes, "Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed" National Committee for Clinical Laboratory Standards 2002
5 Pfaller MA, "Multicenter comparision of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconasole against Candida spp" 45 : 796-802, 2007
6 Asmundsdottir LR, "Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland" 40 : 3489-3492, 2002
7 Mcneil MM., "Fungal infections in: Hospital epidemiology and infection control. 3rd ed" Lippincott Williams and Wilkins 685-707, 2004
8 Joung YH, "Fluconazole susceptibility testing of Candida species by flow cytometry" 54 : 504-508, 2007
9 Lee MK, "Evaluation of disk diffusion test with glucose- and methylene blue-enriched Mueller- Hinton agar for in vitro susceptibility testing of fluconazole against Candida isolates" 25 : 247-251, 2005
10 Nelson SM, "Detection of fluconazoleresistant isolates of Candida glabrata by using an agar screen assay" 41 : 2141-2143, 2003
1 Hospenthal DR, "The role of antifungal susceptibility testing in the therapy of candidiasis" 48 : 153-160, 2004
2 Vandenbossche I, "Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory" 40 : 918-921, 2002
3 Patterson TF, "Simple method for detecting fluconazole-resistant yeasts with chromogenic agar" 34 : 1794-1797, 1996
4 Clinical and Laboratory Standards Institutes, "Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed" National Committee for Clinical Laboratory Standards 2002
5 Pfaller MA, "Multicenter comparision of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconasole against Candida spp" 45 : 796-802, 2007
6 Asmundsdottir LR, "Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland" 40 : 3489-3492, 2002
7 Mcneil MM., "Fungal infections in: Hospital epidemiology and infection control. 3rd ed" Lippincott Williams and Wilkins 685-707, 2004
8 Joung YH, "Fluconazole susceptibility testing of Candida species by flow cytometry" 54 : 504-508, 2007
9 Lee MK, "Evaluation of disk diffusion test with glucose- and methylene blue-enriched Mueller- Hinton agar for in vitro susceptibility testing of fluconazole against Candida isolates" 25 : 247-251, 2005
10 Nelson SM, "Detection of fluconazoleresistant isolates of Candida glabrata by using an agar screen assay" 41 : 2141-2143, 2003
11 Patterson TF, "Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans" 34 : 3237-3239, 1996
12 김태형, "Candida 종에 의한 병원-획득성 요로감염에서 위험인자 분석" 대한의진균학회1 12 (12): 156-162, 2007
13 Rex JH, "Antifungal susceptibility testing: Practical aspects and current challenges" 14 : 643-658, 2001